Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) is now available.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at four store locations in Odisha, Karnataka, and Telangana. These suspensions, issued by respective state Drugs Control Administrations, are expected to result in a potential revenue loss of approximately Rs 5.02 Lacs. The suspensions highlight regulatory compliance challenges and may impact the company’s operations and financial performance in the affected regions.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is known for its extensive network of retail pharmacies across India, catering to a wide range of healthcare needs.
YTD Price Performance: -10.48%
Average Trading Volume: 7,934
Current Market Cap: 90.91B INR
For a thorough assessment of MEDPLUS stock, go to TipRanks’ Stock Analysis page.